Locus 110: LACTB (15q22.2)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs1472631 |
succinylcarnitine |
A/G |
6552 |
0.49 |
0.037 (0.002) |
1.85·10-88 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs1472631 |
| Chromosomal location | Chr15: 61,210,792 (15q22.2) |
| Gene (distance) | LACTB (0) |
| Predicted causal gene | unknown |
| Gene/protein classification | - |
| Metabolite (Pathway) | succinylcarnitine (Krebs cycle; Energy) |
| Biochemical locus-metabolite relationship | Succinylcarnitine is presumably related to succinyl-CoA, a Krebs cycle intermediate. LACTB encodes a beta-lactamase-like protein which has been detected as part of the mitochondrial large ribosomal subunit [11551941]. |
| eQTL associations | - |
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | succinylcarnitine [21886157] |
| Inborn error of metabolism | - |
| Pharmacological information |
| ChEMBL ID | CHEMBL3791 |
| Drug information |
Compounds and one approved drug (Tazobactam) with activity in ChEMBL
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

